#immunotherapy

[ follow ]
#car-t-cell-therapy
Cancer
fromNature
3 days ago

Cancer-fighting immune cells could soon be engineered inside our bodies

CAR T cell therapy has evolved from skepticism in the 1990s to a promising cancer treatment today.
Cancer
fromNature
3 days ago

Cancer-fighting immune cells could soon be engineered inside our bodies

CAR T cell therapy has evolved from skepticism in the 1990s to a promising cancer treatment today.
more#car-t-cell-therapy
Cancer
fromNews Center
1 week ago

Discovering New Ways to Recharge T-Cells Fighting Cancer - News Center

Recent studies reveal mechanisms to enhance T-cell responses, potentially improving cancer immunotherapy treatments.
#health
fromNew York Post
1 week ago
Cancer

Eminent pathologist Richard Scolyer reveals heartbreaking cancer update months after experimental immunotherapy

fromNew York Post
1 week ago
Cancer

Eminent pathologist Richard Scolyer reveals heartbreaking cancer update months after experimental immunotherapy

more#health
#cancer-treatment
Cancer
fromstupidDOPE | Est. 2008
1 month ago

How Immunotherapy Changed My Mom's Cancer Diagnosis: A Thank You to Libtayo and the Medical Teams Behind It | stupidDOPE | Est. 2008

Immunotherapy like Libtayo can significantly improve cancer treatment outcomes, even in complex cases.
OMG science
fromNews Center
3 months ago

Reprogramming Compromised Immune Cells to Fight Cancer - News Center

Researchers have found a way to reprogram immune cells to combat tumors by targeting specific signaling proteins.
Inhibiting proteins AhR and IRAK1 can help convert pro-tumor macrophages back into anti-tumor cells.
Cancer
fromArs Technica
2 weeks ago

A new era in cancer therapies is at hand

New cancer therapies are advancing beyond traditional immunotherapy, providing safer, more effective treatment options for various tumor types.
Cancer
fromstupidDOPE | Est. 2008
1 month ago

How Immunotherapy Changed My Mom's Cancer Diagnosis: A Thank You to Libtayo and the Medical Teams Behind It | stupidDOPE | Est. 2008

Immunotherapy like Libtayo can significantly improve cancer treatment outcomes, even in complex cases.
OMG science
fromNews Center
3 months ago

Reprogramming Compromised Immune Cells to Fight Cancer - News Center

Researchers have found a way to reprogram immune cells to combat tumors by targeting specific signaling proteins.
Inhibiting proteins AhR and IRAK1 can help convert pro-tumor macrophages back into anti-tumor cells.
Cancer
fromArs Technica
2 weeks ago

A new era in cancer therapies is at hand

New cancer therapies are advancing beyond traditional immunotherapy, providing safer, more effective treatment options for various tumor types.
more#cancer-treatment
#cancer-research
Cancer
fromwww.nytimes.com
1 month ago

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.
Cancer
fromwww.nytimes.com
1 month ago

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.
more#cancer-research
fromwww.theguardian.com
1 month ago

Daily peanut exposure can desensitise allergic adults, study suggests

"The findings suggest that the window of opportunity for treating allergies could extend into adulthood, raising the prospect of new treatments for those severely affected."
Mental health
Cancer
fromDecider
1 month ago

Teddi Mellencamp admits she's "really scared" as she reveals "50/50" chance of surviving Stage 4 cancer

Teddi Mellencamp discusses her challenging cancer journey, emphasizing the uncertainty of survival estimates and the emotional toll of her diagnosis.
Alternative medicine
fromwww.theguardian.com
2 months ago

NHS England first in Europe to roll out take-at-home pill for MS patients

The NHS in England will introduce an immunotherapy pill for multiple sclerosis patients, improving treatment accessibility and reducing hospital visits.
Cancer
fromNature
3 months ago

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures - Nature

EGFR mutations in lung adenocarcinoma improve outcomes with TKIs, but resistance often develops, prompting exploration of new immune-based therapies.
Cancer
fromNature
3 months ago

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer - Nature

Vaccine-induced T cells correlate with significantly improved recurrence-free survival in PDAC patients at extended follow-up.
[ Load more ]